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INTRODUCTION
Aortic stiffness, as measured by Aortic Pulse Wave Velocity (aPWV) and Central Pulse Pressure (CPP), increase with healthy aging [1, 2] and independently predict cardiovascular mortality, including stroke [3] [4] [5] . Large artery stiffness is associated with increased cerebral blood flow pulsatility [6] [7] [8] [9] [10] which likely increases the mechanical insult delivered into the cerebral microvasculature [11] and may help to explain the increased frequency of white matter lesions observed in individuals with increased large artery stiffness [12, 13] . In line with this hypothesis, individuals with increased cerebral blood flow pulsatility display increased frequency and volume of white matter hyperintensities [14, 15] which are associated with incidence of stroke and other cerebrovascular disorders [6, [16] [17] [18] [19] .
As the forward-travelling pressure wave propagates throughout the arterial tree it encounters bifurcations and sites of impedance mismatch that result in a proportion of this pressure wave being reflected back to the aorta. This phenomenon is termed pulse wave reflection [20] . Augmentation Index (AIx) can be used as an index of both the reflected pressure waves [21] and myocardial shortening velocity [22] . A greater AIx increases the risk of cardiovascular events, including stroke [23] , target organ damage [19, 24] and white matter hyperintensity volume [25, 26] . In line with this, increased [25] and early wave reflections from the lower body [27] accompany a greater cerebral pulsatility in aged individuals, suggesting that increased AIx may be associated with an increased cerebral blood flow pulsatility and cerebrovascular damage. However, an increased AIx has also been hypothesised to dampen the transmission of highly pulsatile forces travelling from the aorta into the end organ particularly those with a low resistance to flow (e.g. the brain and kidney) [6, 19, 28] .
Therefore, the aim of this study was to further examine the influence of AIx upon cerebral pulsatility in the Middle Cerebral Artery Pulsatility Index (MCAPI) across a wide range of CPP and aPWV values, first, in a cross sectional study design and, second, following acute reductions in AIx with administration of the nitrovasodilator, Glyceryl Trinitrate (GTN) [29, 30] . We hypothesised that AIx modifies the relation between markers of aortic stiffening and cerebral pulsatility. 
MATERIALS AND METHODS

Study Population
Ninety nine individuals (54 females, 45 ± 16 years, 75 ± 15 kg and 170 ± 9 cm, Table 1 ), who were free from current or previous use of anti-hypertensive and/or cardiovascular acting medications and had no diagnosis of cardiovascular disease were recruited and assessed as part of this study. The study protocol information and consent were approved by the Cardiff Metropolitan University ethics committee and the Institutional Review Boards at the University of Texas Southwestern Medical Center at Dallas and Texas Health Presbyterian Hospital Dallas.
Protocols
Height and weight were measured following the completion of a medical history questionnaire where medications were noted. Peripheral (brachial) blood pressure, central (aortic) pulse pressure, aPWV, AIx and MCA blood flow velocity (MCAv) were obtained following at least 15 min of supine rest.
A subset of 25 individuals (14 females, 53 ± 17 years, 74 ± 11 kg and 169 ± 10 cm) were enrolled in the interventional arm of the study, wherein each individual was given one dose of GTN (400-500 µg) while supine. A GTN tablet was positioned sublingually for 3 min after which time any remaining part of the tablet was discarded. Blood pressure (peripheral and central), AIx and MCAPI were measured simultaneously at baseline and at 1, 3, 5, 10, 15, and 20 min post GTN administration.
Hemodynamic Measurements
Blood pressure
Brachial blood pressure was measured whilst supine using a validated semi-automated oscillometric device [31] (HEM-705CP, Omron Corporation and Tango, Suntech Medical Instruments, Raleigh, NC, USA). At baseline, blood pressure was measured in duplicate, or triplicate if two consecutive readings varied appreciably.
Central pulse pressure and augmentation index
Applanation tonometry of the radial artery was used to assess CPP and AIx (SphygmoCor, AtCor Medical, Sydney, Australia). Central (aortic) pressure waves were generated from the radial artery pressure waves using a validated generalized transfer function as previously described [32] . Using the integral software, CPP was calculated as the difference between the aortic systolic and diastolic pressures, while Central Augmentation Pressure (cAP) was calculated as the difference between the second and first aortic systolic pressure peaks (P2 and P1). Pulse wave analysis of the aortic pressure waveform was also used to measure AIx (cAP expressed as a percentage of the aortic pulse pressure). Heart Rate (HR) was determined from the aortic waveform and expressed as beats per minute. Mean Arterial Pressure (MAP) was obtained by integration of the aortic waveform following the measurement and input of brachial systolic and diastolic blood pressures.
Aortic pulse wave velocity
Briefly, aPWV was measured using applanation tonometry (SphygmoCor, AtCor Medical, Sydney, Australia) by sequentially recording electrocardiography gated carotid and femoral artery pressure waveforms, as previously described in detail [33] . Path length for the determination of aPWV was measured as the surface distance between the suprasternal notch and the femoral artery measurement site minus the distance between the suprasternal notch and carotid artery measurement site, using a tape measure.
Cerebral blood flow pulsatility
Cerebral artery blood flow pulsatility (MCAPI) was measured from the left MCA flow velocity profile (MCAv) using 2 MHz pulsed 
Statistical Analysis
Data were analyzed using simple and hierarchical multivariable regression (SPSS v20, IBM, Armonk, NY, USA). Non-normally distributed variables were log transformed. The associations between cerebral blood flow pulsatility, aPWV, CPP and AIx were initially analyzed, together with other hemodynamic variables, using linear and curvilinear regression analyses. A hierarchical multivariable regression model was used thereafter to investigate the parameters that were independently associated with MCAPI. Traditional known confounders such as age and gender were forced into the model. This was followed by the stepwise entry of the linear and quadratic terms of aPWV, CPP, AIx, heart rate and MAP. GTN administration can change heart rate and therefore AIx values obtained during GTN administration were standardized to 75 bpm (AIx75) [37] . The same hierarchical multivariable regression analyses were used to examine the relationships between the linear and quadratic terms of aPWV, CPP, AIx, heart rate and MAP with MCAPI at baseline and following GTN administration. These variables were entered into the model in a stepwise method after age and gender had been forced into the model. A one-way ANOVA was also used to analyze the influence of GTN upon CPP, AIx75 and MCAPI over time. A main effect of time was followed up with using a paired t-test and a Bonferroni correction was applied where appropriate. Statistical significance was set at p ≤ 0.05. Unless otherwise stated, results are reported as mean ± SD. Values reported in the tables, text and figures have been log transformed where necessary.
RESULTS
Cross Sectional Study
Baseline descriptive characteristics, pressure and hemodynamic data of all 99 individuals and a subset of those who received GTN are reported in Table 1 . Univariate regression analysis indicated that MCAPI shared a relationship with age (R 2 = 0.057, b = 0.239; p = 0.018), CPP (R 2 = 0.161, b = 0.401; p = 0.0001, Figure 1 ) and aPWV (R 2 = 0.053, b = 0.230; p = 0.028). After accounting for the effects of age and gender, hierarchical multivariable regression analyses indicated that MCAPI shared an inverse relationship with AIx (R 2 = 0.109, b = −0.515; p = 0.001) and a positive relationship with CPP (R 2 = 0.093, b = 0.570; p = 0.003, Table 2 ). None of the other measured variables shared an independent relationship with MCAPI and were therefore excluded from this regression model. 
Influence of acute reductions in augmentation index upon cerebral pulsatility
Baseline descriptive characteristics, pressure and hemodynamic data of the subset of 25 individuals who received GTN are reported in Table 1 . Relative to baseline values (18 ± 17%) AIx75 was reduced during the 20-min period following GTN administration (main effect of time: p < 0.001) at 3 (10 ± 14%, p < 0.001), 5 (9 ± 15%, p < 0.001), 10 (11 ± 17%, p < 0.001) and 15 min (12 ± 116%, p < 0.001). CPP was not different relative to baseline (36 ± 9 mmHg) at any time point (all p > 0.05). Similarly, despite reductions in AIx75 with GTN, MCAPI was unchanged at 3 (74.6 ± 13.3%), 5 (75.6 ± 11.4%), 10 (76.6 ± 13.0%) and 15 min (75.9 ± 13.7%) relative to baseline (77 ± 12.2%, Main effect of time p = 0.63). The time at which the lowest AIx75 occurred in the 20 min following GTN administration was variable between subjects. Therefore, we compared the lowest AIx75 for each subject with MCAPI at that same time point. The lowest AIx75 following GTN was 5 ± 16% which was lower relative to baseline (p < 0.001). Interestingly, this decrease in AIx75 did not correspond with a change in MCAPI at the same time point relative to baseline (77 ± 12.2% vs. 75.8 ± 13.1%; p = 0.56). However, after accounting for the effects of age and gender, hierarchical multivariable regression analyses indicated that MCAPI shared an inverse relationship with AIx75 (R 2 = 0.019, b = −0.320; p = 0.031) and a positive relationship with CPP (R 2 = 0.042, b = 0.330; p = 0.002) in the 20 min period following GTN administration (Table 3 ).
DISCUSSION
The aim of this study was to examine the influence of AIx upon cerebral pulsatility across a wide range of CPP and aPWV values, first, in a cross sectional study design and, second, following acute reductions in AIx with administration of the nitrovasodilator, GTN [26, 27] . Together, these data indicate that CPP is positively associated and AIx inversely associated with middle cerebral artery blood pulsatility in healthy individuals. These findings have implications for the understanding of the role of CPP and AIx upon cerebral pulsatility.
Both aPWV and CPP share a positive relationship with carotid and cerebral pulsatility in a healthy population [22] , leukoaraiosis patients [35] and a mixed group comprising both healthy individuals and those with cardiovascular disease [36, 37] . Previous reports examining the relationship between AIx and cerebral pulsatility appear to be conflicting. Aortic AIx shares a positive relationship with cerebral flow AIx [24] , while carotid AIx is inversely related with MCAPI [22] . However, the independent influence of AIx upon the relationship between increased CPP and aPWV with cerebral pulsatility index is unknown in a study population comprised exclusively of individuals free from cardiovascular disease, and current and/or prior use of cardiovascular acting medications.
Similar to others [22, 25, [35] [36] [37] our data indicate a positive relationship between CPP and cerebral blood flow pulsatility. However, independent of CPP, these data also indicate a small inverse relationship between AIx and cerebral blood flow pulsatility exists both from cross sectional data and that obtained following acute reduction of AIx75 with GTN. Taken together, these findings suggest that wave reflections may exert a small influence in attenuating increases in cerebral blood flow pulsatility that accompany aortic stiffening and CPP.
Increased cerebral blood flow pulsatility and the accompanying excessive pulsatile shear stress can damage the vascular endothelial layer [34, 35] and blood brain barrier leading to the development of white matter lesions [38] . Furthermore, increased cerebral blood flow pulsatility is associated with large artery vascular remodelling, as evidenced by an increased carotid wall thickness and plaque development [9, 13, 39] , which are themselves predictors of cardiovascular risk [40, 41] . Vascular remodelling occurs with aging and cardiovascular disease [42] leading to further increases in arterial stiffness and pressure pulsatility causing microcirculatory damage [19] , increasing the risk of stroke and the development of white matter lesions [10, 19, 36, [43] [44] [45] . An increased transmission of pulsatile blood flow into the brain, secondary to large artery stiffening, may help explain the independent association between large artery stiffness and stroke [3, 5, 46] . Furthermore the inverse relationship observed here between AIx75 and MCAPI suggests that increased AIx may attenuate, albeit weakly, the transmission of increased pulsatile flow into the cerebral vasculature, perhaps due to aortic stiffening in a healthy population.
Glyceryl trinitrate and other endothelium-independent vasodilators are often prescribed to individuals with cardiovascular disease, likely in the presence of aortic stiffening. With increasing age, the middle cerebral arteries exhibit impaired myogenic response to increased pulsatility that potentially contributes to distal cerebral microvascular damage [47] and intracerebral haemorrhage [48] . Following GTN administration, AIx75 was lowered while CPP remained unchanged relative to baseline. Throughout this period, AIx was inversely associated with cerebral pulsatility. While the association was weak it suggests that decreases in AIx75 are accompanied by small increases in cerebral pulsatility following GTN. While somewhat speculative, repeated and/or prolonged administration of GTN (or similar endothelium-independent vasodilators) may result in greater decreases in AIx75 and accompany increased transmission of pulsatile flow into the cerebral vasculature, particularly in individuals with aortic stiffening. As such these findings may have implications for stroke and other cerebral vascular disorders associated with cerebral blood flow pulsatility [14, 15] . While medications such as GTN have clearly cardioprotective effects, decreases in AIx in individuals with aortic stiffening may expose the cerebral microvasculature to an increased flow pulsatility and influence the incidence of stroke and other cerebral vascular disorders related to cerebral pulsatility.
Limitations
First, the strength of the prediction of the variance in MCAPI from alterations in AIx found here is low. Despite this, these data suggest that to some extent AIx shares an inverse relationship with cerebral pulsatility that is independent of age, gender, height, BMI and other traditional hemodynamic parameters that would be reasonably expected to influence cerebral pulsatility. In addition, the observation regarding an effect of AIx on MCAPI during GTN administration are consistent when investigating the cross-sectional data. To the best of our knowledge, these findings in a healthy population are novel. Second, the measurement of cerebral pulsatility was obtained using transcranial Doppler measures of blood velocity from the MCA. The MCA is responsible for a large majority (~80%) of the blood perfusing the cerebral circulation. Given this, changes in pulsatility in this vessel likely influences cerebral health. That said, we are unable to ascertain whether the association between AIx and cerebral pulsatility with and without GTN administration was also evident in other cerebral arteries. This warrants further investigation.
CONCLUSION
In a healthy population, the relationship between CPP and cerebral pulsatility is weakly modified by AIx in steady state resting conditions and following acute reductions in AIx75 with GTN.
